BCM
MRK icon

Banyan Capital Management’s Merck MRK Stock Holding History

Banyan Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$751K Sell
5,841
-308
-5% -$36.1K 0.33% 29
2026
Q1 		$740K Buy
6,149
+186
+3% +$21.5K 0.32% 31
2025
Q4 		$628K Sell
5,963
-426
-7% -$40K 0.27% 31
2025
Q3 		$536K Buy
+6,389
New +$526K 0.24% 33

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Banyan Capital Management's MRK Position: Q2 2026 in Review

Banyan Capital Management reduced its Merck (MRK) stake by 5% in Q2 2026, selling an estimated $36.1K and leaving 5,841 shares worth $751K. The position accounts for 0.33% of the portfolio, ranked #29.

Banyan Capital Management first reported a position in MRK in Q3 2025 and has held it in 4 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Banyan Capital Management held 5,841 shares of Merck worth $751K as of Q2 2026.
  • Banyan Capital Management sold 308 Merck shares in Q2 2026, an estimated $36.1K.
  • Merck made up 0.33% of Banyan Capital Management's portfolio in Q2 2026, its #29 holding.
  • Banyan Capital Management first reported a position in Merck in Q3 2025 and has held it in 4 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Banyan Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.